Beleave Stock Net Asset
Beleave fundamentals help investors to digest information that contributes to Beleave's financial success or failures. It also enables traders to predict the movement of Beleave Pink Sheet. The fundamental analysis module provides a way to measure Beleave's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Beleave pink sheet.
Beleave |
Beleave Company Net Asset Analysis
Beleave's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Beleave Net Asset | 23.61 M |
Most of Beleave's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beleave is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Beleave has a Net Asset of 23.61 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.
Beleave Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beleave's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Beleave could also be used in its relative valuation, which is a method of valuing Beleave by comparing valuation metrics of similar companies.Beleave is currently under evaluation in net asset category among its peers.
Beleave Fundamentals
| Return On Equity | -1.27 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 5.66 K | |||
| Shares Outstanding | 566.37 M | |||
| Price To Earning | (4.44) X | |||
| Price To Book | 0 X | |||
| Price To Sales | 0.0002 X | |||
| Revenue | 2.37 M | |||
| Gross Profit | 816.46 K | |||
| EBITDA | (30.76 M) | |||
| Net Income | (33.78 M) | |||
| Cash And Equivalents | 120.41 K | |||
| Debt To Equity | 2.44 % | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.47 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 27.8 | |||
| Market Capitalization | 566 | |||
| Total Asset | 23.61 M | |||
| Z Score | -3.3 | |||
| Net Asset | 23.61 M |
About Beleave Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beleave's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beleave using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beleave based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |